GL1X · GenesisL1 explorer

MolNFT v2 · #204649 · protein

8BB3: Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1)

8BB3 · Elongin-B: “Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1)”. X-ray diffraction at 1.8, 2 ligands (Q3X, SCN), 4 pockets (best druggability 0.77). MolNFT v2 #204649 on GenesisL1…

3D structure of 8BB3: Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1) (MolNFT v2 / PDB Bank)
3D structure of 8BB3: Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1) (MolNFT v2 / PDB Bank)
PDB
8BB3
Type
protein
Length
642 residues
Chains
4
Method
x-ray diffraction
Authors
Kraemer, A., Doelle, A., Knapp, S., Structural Genomics Consortium (SGC)
Deposited
10/12/22
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.8
Source
Homo sapiens
Molecule
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; WD repeat-containing…
UniProt
Q15370, Q15369, P40337, P61964
Ligands
Q3X, SCN
Pockets
4 · best druggability 0.77

Structure

x-ray diffraction · resolution 1.8 · 4 distinct chains · 16% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
JElongin-Bprotein10317% helix, 39% strandQ15370
KElongin-Cprotein8748% helix, 15% strandQ15369
Lvon Hippel-Lindau disease tumor suppressorprotein15326% helix, 29% strandP40337
BWD repeat-containing protein 5protein2990% helix, 52% strandP61964

Ligands and binding sites

  • Q3X · ~{N}-[5-[4-[2-[2-[2-[2-[3-[[3,3-dimethyl-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamoyl]-4-oxidanyl-pyrrolidin-1-yl]-1-oxidanylidene-butan-2-yl]amino]-3-oxidanylidene-propoxy]ethoxy]ethoxy]ethoxy]ethylcarbamoyl]phenyl]-2-(4-methylpiperazin-1-yl)phenyl]-6-oxidanylidene-4-(trifluoromethyl)-3~{H}-pyridine-3-carboxamide · ligand · chains L, B
  • SCN · Thiocyanate ion · ion · 15 copies · chains J, K, L, B
  • EDO · 1,2-ethanediol · additive · 13 copies · chains J, K, L, B
  • P6G · Hexaethylene glycol · additive · chains K

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17140.770.8267EDO
21790.470.7627SCN
31120.370.7426Q3X
4660.350.7612P6G

Interfaces

4 interfaces between chains.

  • J–K · 1137 Ų buried · 13 hydrogen bonds · protein-protein
  • K–L · 1045 Ų buried · 12 hydrogen bonds · protein-protein
  • J–L · 177 Ų buried · 1 hydrogen bond · protein-protein
  • L–B · 42 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • P40337 · AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40337) · a predicted model of the same protein · chain L against A, TM-score 0.99
  • Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain K against A, TM-score 0.98
  • Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain J against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.